Neuro Sciences | by Dr. Mahendra Kumar Manocha | Published on 02/02/2023
Glioblastoma is a type of cancer which occurs in the brain or spinal cord. Cancer forms from the type of cells called astrocytes which support nerve cells. The condition can occur at any age but occur more frequently in the older population. Also, men are more likely to be diagnosed with glioblastoma than women. Untreated glioblastoma can cause worse headaches, nausea, vomiting and seizures.
Glioblastoma can be classified into different types - primary glioblastoma and secondary glioblastoma. While the former type of glioblastoma tends to be more aggressive and spreads rapidly, the latter develops gradually. The survival rate for secondary glioblastoma tends to be better than the primary. This blog contains information about glioblastoma and how you can manage the symptoms. Please note that this blog is only for informational purposes, and to know the extent of your condition, you must consult the best neurologist doctor in Kolkata.
Glioblastoma symptoms vary depending on the medical condition of the patient and the degree of the condition. The condition progresses rapidly and increases the pressure on the brain which leads to signs and symptoms. Depending on the location of the tumour, glioblastoma symptoms include -
There is no exact reason for glioblastoma but certain factors can contribute to the progression of the condition. A history of exposure to radiation, especially in the head for the treatment of brain tumours or cancers can also increase the risk of glioblastoma. Additionally, rare congenital disorders which cause genetic mutations like Turcot syndrome, neurofibromatosis type 1, and Li-Fraumeni syndrome are considered risk factors. Genetic mutations are mostly a result of chronic exposure to chemicals and other cancer-causing agents.
Age and gender are also considered risk factors. Patients aged 50 and above are more prone to get diagnosed with glioblastoma. So, in case you are experiencing early signs and symptoms, it is crucial you get in touch with the neurologist for early treatment.
Glioblastoma treatment varies depending on several factors. The aim of the treatment is to remove the tumour or prevent the tumour growth from progressing further. Several options for glioblastoma treatment can be done based on the patient’s medical condition and the degree of severity. Consider the following options if you are planning to undergo the treatment -
Glioblastoma is the most common type of malignant brain cancer which can grow fast and spread rapidly. Most patients with glioblastoma symptoms often remain unaware of the condition which can lead to serious complications. Treatment options for glioblastoma vary depending on the severity of the condition and the preference of the patient. Studies reveal that in the case of severe glioblastoma, 25% of patients live past one year, 8-12% up to two years and only 5% up to five years. However, these numbers do not predict the outcome for any patient. It is important to be aware of the early signs and get treated on time.
Glioblastoma diagnosis involves the following tests -
Most patients with glioblastoma are cured if the condition is detected in the early stages. However, glioblastoma cure depends on the medical health of the patient and the extent of severity. The surgeons combine several treatment options to produce effective results which can help manage the symptoms in the long run.
While the process of death from glioblastoma is not sudden, prolonged growth of the tumour in the brain can lead to weakness, difficulty in swallowing, seizures, etc. Apart from that, there is a persistent change in blood pressure, heartbeat and breathing.
Glioma is one of the most common types of primary brain cancer that develop from cells surrounding the nerve cells in the brain or spinal cord. On the other hand, glioblastoma is the classification of glioma which is more aggressive.
No, a general notion indicates that glioblastomas are not inherited. However, the risk of developing this type of brain cancer increases in people diagnosed with certain genetic cancer syndromes.